Novo Nordisk A/S
- U.S. News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Patients will be able to access Zepbound single-dose vials at Ro Coutesy: Ro Direct-to-consumer health-care startup Ro on Wednesday said…
Read More » - News
The weight-loss drug boom has become one of the internet’s biggest scams
A production line of Wegovy injection pens for the Asian market at the Novo Nordisk A/S pharmaceutical manufacturing facility in…
Read More » - U.S. News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by…
Read More » - U.S. News
Eli Lilly’s Zepbound causes greater weight loss than Novo Nordisk’s Wegovy in head-to-head trial
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by…
Read More » - News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty…
Read More » - U.S. News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial…
Read More » - U.S. News
Novo Nordisk’s Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Packages containing syringes of the medications Wegovy, Ozempic and Mounjaro at a shop in Mitte, Germany, July 11, 2024. Picture…
Read More » - U.S. News
Novo Nordisk’s diabetes drug Ozempic may reduce the risk of Alzheimer’s disease, study says
Steve Christo – Corbis | Corbis News | Getty Images Novo Nordisk‘s blockbuster diabetes drug Ozempic may reduce the risk…
Read More » - U.S. News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent compounding pharmacies from making unapproved and often cheaper…
Read More » - Europe
Novo and Lilly contender Zealand Pharma heralds its obesity drug alternative: It’s our ‘crown jewel’
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated…
Read More »
